CN Stock MarketDetailed Quotes
600267 Zhejiang Hisun Pharmaceutical
- 8.33
- -0.12-1.42%
Market Closed Nov 1 15:00 CST
10.06BMarket Cap-490000P/E (TTM)
8.52High8.29Low152.11KlotVolume8.46Open8.45Pre Close127.70MTurnover1.27%Turnover RatioLossP/E (Static)1.21BShares10.7052wk High1.22P/B9.98BFloat Cap6.4352wk Low9.30Limit Up1.20BShs Float27.24Historical High7.61Limit Down2.72%Amplitude1.42Historical Low--Dividend TTM8.40Avg Price74.75KlotAsk--Div YieldTTM100Lot Size74.66KlotBid
Zhejiang Hisun Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -7.28%8.37B | -11.17%5.43B | -14.09%2.7B | -7.53%11.07B | 3.68%9.02B | 5.98%6.12B | 6.79%3.14B | -0.50%11.97B | -2.25%8.7B | 1.79%5.77B |
| Refunds of taxes and levies | 15.30%51.15M | -1.22%32.7M | -92.35%2.01M | -73.47%43.02M | -71.91%44.36M | -71.03%33.1M | 91.97%26.33M | 142.99%162.18M | 141.10%157.93M | 340.96%114.24M |
| Cash received relating to other operating activities | 2.14%346.24M | 3.28%269.96M | 50.90%197.64M | -21.66%391.1M | -8.30%338.97M | 6.07%261.38M | -6.36%130.97M | 39.91%499.25M | 29.94%369.67M | 34.21%246.42M |
| Cash inflows from operating activities | -6.84%8.76B | -10.53%5.74B | -12.13%2.9B | -8.94%11.5B | 1.91%9.41B | 4.55%6.41B | 6.57%3.3B | 1.43%12.63B | -0.25%9.23B | 4.30%6.13B |
| Goods services cash paid | -9.91%4.13B | -12.43%2.76B | -10.90%1.46B | -2.34%5.48B | 12.93%4.59B | 19.07%3.15B | 15.00%1.64B | -5.81%5.61B | -12.45%4.06B | -12.79%2.65B |
| Staff behalf paid | -5.49%1.25B | -6.28%883.85M | -9.20%525.26M | -1.80%1.7B | 0.10%1.32B | 0.51%943.11M | -0.62%578.51M | 5.66%1.73B | 4.12%1.32B | 5.24%938.29M |
| All taxes paid | -11.02%500.27M | -23.32%321.45M | -23.33%179.36M | -17.10%686.92M | -10.94%562.23M | -10.94%419.23M | -10.30%233.94M | 12.93%828.61M | -1.94%631.31M | -3.12%470.74M |
| Cash paid relating to other operating activities | -11.69%1.42B | -14.38%988.19M | -23.01%413.41M | -10.95%2.13B | -7.21%1.61B | 12.36%1.15B | 0.28%536.99M | 0.31%2.39B | 5.37%1.74B | -9.72%1.03B |
| Cash outflows from operating activities | -9.62%7.31B | -12.61%4.95B | -13.72%2.58B | -5.36%10B | 4.29%8.08B | 11.51%5.67B | 6.60%2.99B | -1.41%10.56B | -5.48%7.75B | -8.42%5.08B |
| Net cash flows from operating activities | 10.18%1.46B | 5.35%781.43M | 3.49%315.09M | -27.26%1.5B | -10.59%1.32B | -29.23%741.73M | 6.24%304.46M | 18.96%2.07B | 40.62%1.48B | 219.39%1.05B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | -98.75%942.04K | -93.05%25.44M | 62.26%24.5M | 62.26%24.5M | -95.39%75.66M | -76.69%365.84M | -98.71%15.1M |
| Cash received from returns on investments | 0.92%15.91M | 0.92%15.91M | ---- | -0.25%14.79M | 0.97%15.77M | 2.11%15.77M | 103.84%1.6M | -35.25%14.83M | -34.77%15.61M | -33.04%15.44M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -94.16%1.01M | -14.08%883.86K | -61.16%278.31K | -71.12%26.46M | 27.19%17.27M | -92.62%1.03M | -94.86%716.57K | -55.02%91.62M | -92.83%13.58M | -91.70%13.94M |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | -46.84%23.1M | -2.49%22.97M | -82.29%4.17M | --4.17M | --43.45M | --23.56M | --23.56M |
| Cash received relating to other investing activities | 132.85%21.63M | 134.11%20.32M | 3,736.63%20.1M | -47.50%7.88M | 114.39%9.29M | 99.27%8.68M | 427.96%523.82K | 510.45%15M | -22.71%4.33M | 41.90%4.36M |
| Cash inflows from investing activities | -57.52%38.55M | -31.46%37.11M | -35.35%20.38M | -69.58%73.17M | -78.54%90.74M | -25.21%54.15M | 5.35%31.52M | -87.14%240.56M | -76.35%422.93M | -94.68%72.4M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -53.24%116.37M | -66.18%66.35M | -77.20%34.4M | -54.76%240.04M | -39.20%248.85M | -36.06%196.17M | -26.44%150.9M | -14.74%530.62M | 8.92%409.26M | 16.08%306.82M |
| Cash paid to acquire investments | 19,517.23%39.23M | 14,900.00%30M | 14,900.00%30M | -98.73%1.5M | -99.76%200K | -99.76%200K | -99.43%200K | -93.18%118.72M | -95.08%84.97M | -93.82%84.97M |
| Cash paid relating to other investing activities | -98.22%3.25M | -99.35%1.18M | -91.25%912.32K | 0.19%170.33M | 416.66%182.11M | 417.64%181.57M | -67.14%10.42M | 32,406,160.13%170M | 1,044.59%35.25M | 4,029.08%35.08M |
| Cash outflows from investing activities | -63.16%158.85M | -74.19%97.53M | -59.56%65.31M | -49.73%411.87M | -18.57%431.16M | -11.46%377.93M | -40.58%161.52M | -65.34%819.34M | -74.86%529.47M | -73.96%426.86M |
| Net cash flows from investing activities | 64.66%-120.3M | 81.34%-60.42M | 65.43%-44.94M | 41.48%-338.71M | -219.49%-340.41M | 8.65%-323.79M | 46.26%-130M | -17.33%-578.78M | 66.47%-106.55M | -27.55%-354.46M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -68.40%323.01M | -66.34%343.29M | -93.64%43.29M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 199.72%299.72M | ---- | --20M |
| Cash from borrowing | 18.13%3.15B | 17.56%2.44B | 29.52%1.82B | -16.82%3.83B | -15.53%2.67B | -16.42%2.08B | -24.45%1.4B | -30.73%4.61B | -41.19%3.16B | -35.83%2.49B |
| Cash received relating to other financing activities | 14,900.00%300M | 14,900.00%300M | --300M | -97.81%25.99M | -99.73%2M | -99.56%2M | ---- | 18.92%1.19B | 50.44%751.25M | -9.56%451.63M |
| Cash inflows from financing activities | 29.28%3.45B | 31.88%2.74B | 50.91%2.12B | -36.95%3.86B | -37.22%2.67B | -30.23%2.08B | -25.39%1.4B | -29.45%6.12B | -38.27%4.25B | -41.02%2.98B |
| Borrowing repayment | 23.54%2.95B | 29.03%2.03B | 21.45%1.21B | -39.17%3.77B | -47.37%2.39B | -41.84%1.58B | -38.20%1B | -30.20%6.2B | -36.48%4.53B | -47.25%2.71B |
| Dividend interest payment | -64.92%112.23M | -72.75%76.85M | -0.89%38.03M | -6.54%356.3M | -3.03%319.91M | 0.32%282.01M | -36.62%38.37M | -8.64%381.25M | -3.06%329.91M | 1.57%281.11M |
| Cash payments relating to other financing activities | 155.93%1.87B | 141.01%1.56B | 259.20%1.14B | -29.54%731.5M | -13.59%729.48M | -7.27%645.5M | 5,804.05%316M | -27.90%1.04B | 16.61%844.19M | -1.94%696.14M |
| Cash outflows from financing activities | 43.42%4.93B | 46.44%3.67B | 76.28%2.39B | -36.23%4.86B | -39.81%3.43B | -32.10%2.5B | -19.57%1.35B | -29.05%7.62B | -30.41%5.71B | -39.79%3.69B |
| Net cash flows from financing activities | -92.80%-1.47B | -117.86%-923.61M | -671.19%-271.8M | 33.29%-1B | 47.38%-764.64M | 39.99%-423.95M | -75.59%47.58M | 27.42%-1.51B | -10.97%-1.45B | 33.99%-706.42M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -24.02%2.6M | -68.61%1.52M | 207.75%892.11K | -27.71%4.72M | 0.45%3.42M | 0.53%4.84M | -165.00%-827.93K | 1,187.25%6.53M | 233.71%3.4M | 831.27%4.81M |
| Net increase in cash and cash equivalents | -162.14%-136.36M | -17,017.37%-201.07M | -100.34%-755.36K | 1,479.55%164.47M | 378.95%219.42M | 85.30%-1.17M | -8.17%221.22M | 98.57%-11.92M | 86.41%-78.66M | 99.22%-7.99M |
| Add:Begin period cash and cash equivalents | 14.12%1.33B | 14.12%1.33B | 14.12%1.33B | -1.01%1.17B | -1.01%1.17B | -1.01%1.17B | -1.01%1.17B | -41.39%1.18B | -41.39%1.18B | -41.39%1.18B |
| End period cash equivalent | -13.82%1.19B | -3.04%1.13B | -4.15%1.33B | 14.12%1.33B | 26.05%1.38B | -0.44%1.16B | -2.23%1.39B | -1.01%1.17B | -23.16%1.1B | 18.33%1.17B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data